Cortona 2020 Program Details
Planning is under way!
Please check back for updates!
A summary of each session is included below; further details will be available soon. Each session will include one or more panel discussions, by popular demand of IFPAC attendees.
Chair: Mel Koch
The plenary session will begin with overviews of the Pharma and Biotech industries and the current regulatory landscape. Following will be exciting talks on innovations such as cell and gene therapy and personalized medicine. Delegates will also learn from a non-pharma/biotech company that is innovative while regulated. This will be an engaging and diverse plenary session to begin the conference!
Tomorrow's World: Big Data & Artificial Intelligence
Co-Chairs: Ursula Busse and David Churchward
This session will cover applications of big data in large scale and personal scale manufacturing, cloud-based solutions, big data integrity and quality considerations. Next, presenters will dive into the world of artifical intelligence...what it is, case studies, data sets in AI, and regulatory considerations.
Biopharmaceutical Manufacturing & Innovation
Co-Chairs: Ronan Farrell and Roger Nosal
Topics may include cell and gene therapy, innovations in biologics manufacturing, continuous manufacturing, mRNA manufacturing technology, modeling, and regulatory aspects of manufacturing controls and innovation.
Advanced Analytics and Process Controls
Co-Chairs: Ferdinando Aspesi and Ronan Farrell
This session will focus on the newest analytical controls. More details coming soon!
Global Regulatory and Harmonization Initiatives
Co-Chairs: Larry Lee, Nick Lee and Moheb Nasr
This session will have two main components. First we'll look at current ICH guidelines under development and future ICH quality strategy. Second, global CMC regulatory and pharmacopeial initiatives will be presented by experts from around the globe. Ample time for discussion will follow each section.
Wrap-Up Session & Action Planning Meeting
Numerous opportunities are provided during the conference for pharmaceutical thought leaders to discuss and evaluate progress made to date and to propose new ways to introduce innovation and improve manufacturing control and process optimization. Participation of key regulators is fundamental to achieve successful outcome. In this session we plan to assess Cortona 2020 progress and seek feedback from participants, vendors and speakers. Future Cortona meeting planning will be based on the outcome of this session. It is also likely to publish a white paper summarizing Cortona 2020 presentations, posters and wrap-up session key findings.
All meeting attendees are invited to join the organizing committee to participate in the wrap-up session.
Exhibition 5-7 October, 2020 - Table top displays and sponsorship opportunities are available for demonstrating products or services before a specialized audience.